Strategic philanthropy in advanced therapies

Learn about our GMP-compliant facility

Learn about our Industry Network

June 2-11, Toronto, Ontario

From hearing from industry experts on our podcast, to understanding an insider’s perspective on stem cells and regenerative medicine on Signals blog, to reading reports and journal articles, to diving into OmniaBio’s blog posts that provide technical information related to the manufacturing of cell and gene therapies, our educational resources share everything you need to know.

CCRM enables the development and commercialization of cell and gene therapies and regenerative medicine technologies. Using a collaborative approach customized to each project, we launch and scale companies at the interface between academia and industry.

CCRM is a catalyst for commercializing regenerative medicine-based technologies and cell and gene therapies. We enable product development through the unique translational platforms that address the key bottlenecks in regenerative medicine commercialization.